Perrigo Company Plc
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Perrigo Company Plc - overview
Established
1887
Location
Dublin, -, Ireland
Primary Industry
Pharmaceuticals
About
Perrigo Company Plc is a global leader in self-care products, dedicated to enhancing consumer health and wellness through a wide variety of over-the-counter medications and personal care solutions. Perrigo Company Plc, founded in 1887, is headquartered in Dublin, Ireland. The company specializes in self-care products, emphasizing consumer health management. Perrigo has evolved its business strategy over the years, focusing on expanding its product offerings and improving accessibility for consumers.
The current CEOs are Israel Birenbaum and Patrick Lockwood-Taylor. Perrigo Company Plc specializes in a comprehensive range of high-quality self-care products, empowering consumers to proactively manage their health. Core offerings include over-the-counter medications, nutritional supplements, personal care items, and topical solutions. Key product categories encompass pain relief, digestive health, allergy relief, hair regrowth treatments, and personal lubricants.
Perrigo's products cater to consumers seeking affordable solutions for self-managed health conditions, ensuring efficacy and safety across various retail channels, including pharmacies, grocery stores, and e-commerce platforms in North America, Europe, and select international markets. In 2021, Perrigo Company Plc reported a revenue of USD 4. 14 bn and an EBITDA of USD 718. 80 mn.
The company generates revenue through direct-to-consumer sales and partnerships with retailers and wholesalers, utilizing a structured pricing strategy for bulk purchases and direct sales.
Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceutical Research & Development
Website
www.perrigo.com
Verticals
Manufacturing
Total Amount Raised
Subscriber access only
Perrigo Company Plc - timeline of key events
Perrigo Company Plc - financials
| Fiscal Year Ended | Jun 28, 2014 | Jun 27, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 4,060,800,000 | 4,603,900,000 | 5,280,600,000 | 4,946,200,000 | 4,731,700,000 | 4,837,400,000 | 4,088,200,000 | - | - | - |
| % Revenue Growth (YoY) | - | 13.4% | - | - | (4.3%) | 2.2% | (15.5%) | - | - | - |
| EBITDA (USD) | 925,900,000 | 1,296,500,000 | (1,567,400,000) | 1,020,600,000 | 652,000,000 | 596,900,000 | 647,600,000 | - | - | - |
| Operating Income (USD) | 567,000,000 | 747,700,000 | (1,999,700,000) | 598,200,000 | 236,500,000 | 204,800,000 | 265,200,000 | - | - | - |
| Operating Margin | 14.0% | 16.2% | (37.9%) | 12.1% | 5.0% | 4.2% | 6.5% | - | - | - |
| % EBITDA Margin | 22.8% | 28.2% | (29.7%) | 20.6% | 13.8% | 12.3% | 15.8% | - | - | - |
| NET Income (USD) | 205,300,000 | 128,000,000 | (4,012,800,000) | 119,600,000 | 131,000,000 | 146,100,000 | (162,600,000) | - | - | - |
| % Net Margin | 5.1% | 2.8% | (76.0%) | 2.4% | 2.8% | 3.0% | (4.0%) | - | - | - |
Perrigo Company Plc - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on, LP Direct, Trade Sale | Completed | HRA Pharma Rare Disease | - | ||||||||
| Trade Sale | Announced | HRA Pharma Rare Disease | - | ||||||||
| Buyout | Completed | Padagis LLC | - | ||||||||
| Buyout | Completed | Perrigo's Prescription Pharmaceuticals Business | - | ||||||||
| Corporate Carve Out | Completed | Rosemont Pharmaceuticals Limited | - |
Displaying 1 - 5 of 11
Perrigo Company Plc - employee data
Perrigo Company Plc - key contacts
| Name | Position | Start Date | End Date | Vcard | Bio | ||
|---|---|---|---|---|---|---|---|
| Board Member | BM | ||||||
| Chairman Of The Board at Lumenis | BM |
BM Board Member
Want to see more?
Request a demo for full access to this profile
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.